HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Daiki Omata Selected Research
Daiki Omata Research Topics
Disease
20
Neoplasms (Cancer)
12/2022 - 01/2010
2
Human Influenza (Influenza)
08/2020 - 01/2019
1
Glioblastoma (Glioblastoma Multiforme)
11/2023
1
Uterine Cervical Neoplasms (Cancer of the Cervix)
06/2021
1
Shock
03/2016
1
Hyperthermia
01/2013
1
Mucositis
05/2011
1
Kaposi Sarcoma (Kaposi's Sarcoma)
05/2011
1
Ovarian Neoplasms (Ovarian Cancer)
05/2011
Drug/Important Bio-Agent (IBA)
9
Liposomes (Liposome)
IBA
03/2016 - 01/2010
5
Peptides (Polypeptides)
IBA
07/2013 - 02/2010
4
liposomal doxorubicin (Doxil)
FDA Link
12/2021 - 05/2011
4
Lipids
IBA
06/2021 - 01/2020
4
Syndecan-2
IBA
05/2011 - 01/2010
3
Lipid Nanoparticles
IBA
08/2020 - 01/2019
3
Ligands
IBA
05/2011 - 02/2010
2
Cisplatin (Platino)
FDA Link
Generic
11/2023 - 06/2021
2
Vaccine Adjuvants
IBA
12/2022 - 01/2019
2
1-dodecylpyridoxal (PLD)
IBA
12/2021 - 06/2021
2
Contrast Media
IBA
11/2020 - 07/2013
2
Vaccines
IBA
08/2020 - 01/2019
2
Doxorubicin (Adriamycin)
FDA Link
Generic
02/2013 - 05/2011
2
Syndecans
IBA
05/2011 - 02/2010
2
Laminin (Merosin)
IBA
05/2011 - 08/2010
1
Therapeutic Uses
IBA
11/2023
1
Temozolomide (Temodar)
FDA Link
Generic
11/2023
1
Antineoplastic Agents (Antineoplastics)
IBA
11/2023
1
Luciferases
IBA
11/2023
1
Prodrugs
IBA
01/2022
1
Glucuronidase
IBA
01/2022
1
Enzymes
IBA
01/2022
1
Bevacizumab (Avastin)
FDA Link
06/2021
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
06/2021
1
Antigens
IBA
08/2020
1
CPG-oligonucleotide
IBA
01/2019
1
Biocompatible Materials (Biomaterials)
IBA
07/2013
1
laminin A
IBA
02/2010
Therapy/Procedure
10
Therapeutics
11/2023 - 01/2010
5
Microbubbles
11/2023 - 01/2020
5
Immunotherapy
12/2022 - 01/2013
2
Precision Medicine
08/2020 - 06/2015
1
Immunomodulation
04/2022
1
Drug Therapy (Chemotherapy)
06/2021